These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2283041)

  • 1. Effect of prior treatment with Clostridium perfringens epsilon toxin inactivated by various agents on lethal, pressor and contractile activities of the toxin.
    Nagahama M; Takahashi T; Sakurai J
    FEMS Microbiol Lett; 1990 Oct; 60(1-2):59-62. PubMed ID: 2283041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inactivation of Clostridium perfringens epsilon toxin by treatment with tetranitromethane and N-acetylimidazole.
    Sakurai J; Nagahama M
    Toxicon; 1987; 25(3):279-84. PubMed ID: 2884756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino groups in Clostridium perfringens epsilon prototoxin and epsilon toxin.
    Sakurai J; Nagahama M
    Microb Pathog; 1986 Oct; 1(5):417-23. PubMed ID: 2907772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraction induced by Clostridium perfringens epsilon toxin in the isolated rat ileum.
    Sakurai J; Nagahama M; Takahashi T
    FEMS Microbiol Lett; 1989 Apr; 49(2-3):269-72. PubMed ID: 2545518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Clostridium perfringens epsilon toxin on the cardiovascular system of rats.
    Sakurai J; Nagahama M; Fujii Y
    Infect Immun; 1983 Dec; 42(3):1183-6. PubMed ID: 6315593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium perfringens beta-toxin is sensitive to thiol-group modification but does not require a thiol group for lethal activity.
    Nagahama M; Kihara A; Miyawaki T; Mukai M; Sakaguchi Y; Ochi S; Sakurai J
    Biochim Biophys Acta; 1999 May; 1454(1):97-105. PubMed ID: 10354519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxyl groups in Clostridium perfringens epsilon toxin.
    Sakurai J; Nagahama M
    Microb Pathog; 1987 Dec; 3(6):469-74. PubMed ID: 2904641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of one tryptophan residue in the lethal activity of Clostridium perfringens epsilon toxin.
    Sakurai J; Nagahama M
    Biochem Biophys Res Commun; 1985 Apr; 128(2):760-6. PubMed ID: 2859854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Clostridium perfringens epsilon toxin on rat isolated aorta.
    Nagahama M; Iida H; Sakurai J
    Microbiol Immunol; 1993; 37(6):447-50. PubMed ID: 8231959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential conformational environment of tryptophan in epsilon native prototoxin and active toxin from Clostridium perfringens type D.
    Kumar A; Kumar S; Sarma Dagger PV; Sharma Double Dagger AK
    J Biochem Mol Biol Biophys; 2002 Apr; 6(2):147-50. PubMed ID: 12186772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of various biological activities of Clostridium perfringens alpha toxin by chemical modification.
    Sakurai J; Fujii Y; Torii K; Kobayashi K
    Toxicon; 1989; 27(3):317-23. PubMed ID: 2728024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of toxicity of Clostridium perfringens epsilon toxin.
    Bokori-Brown M; Savva CG; Fernandes da Costa SP; Naylor CE; Basak AK; Titball RW
    FEBS J; 2011 Dec; 278(23):4589-601. PubMed ID: 21518257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known.
    Alves GG; Machado de Ávila RA; Chávez-Olórtegui CD; Lobato FC
    Anaerobe; 2014 Dec; 30():102-7. PubMed ID: 25234332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Clostridium perfringens alpha toxin on contraction of isolated guinea-pig diaphragm.
    Sakurai J; Tsuchiya Y; Ochi S; Fujii Y
    Microbiol Immunol; 1991; 35(6):481-6. PubMed ID: 1921763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutagenesis of histidine residues in Clostridium perfringens alpha-toxin.
    Nagahama M; Okagawa Y; Nakayama T; Nishioka E; Sakurai J
    J Bacteriol; 1995 Mar; 177(5):1179-85. PubMed ID: 7868589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain.
    Nagahama M; Sakurai J
    Infect Immun; 1992 Mar; 60(3):1237-40. PubMed ID: 1541539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Clostridium perfringens epsilon toxin by β-cyclodextrin derivatives.
    Robinson TM; Jicsinszky L; Karginov AV; Karginov VA
    Int J Pharm; 2017 Oct; 531(2):714-717. PubMed ID: 28750897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan content of Clostridium perfringens epsilon toxin.
    Sakurai J; Nagahama M
    Infect Immun; 1985 Jan; 47(1):260-3. PubMed ID: 2856914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex.
    Petit L; Gibert M; Gillet D; Laurent-Winter C; Boquet P; Popoff MR
    J Bacteriol; 1997 Oct; 179(20):6480-7. PubMed ID: 9335299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enteric toxins of Clostridium perfringens.
    Smedley JG; Fisher DJ; Sayeed S; Chakrabarti G; McClane BA
    Rev Physiol Biochem Pharmacol; 2004; 152():183-204. PubMed ID: 15517462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.